Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The incidence and magnitude of fibrinolytic activation in trauma patients: a rebuttal.

Literature DB >> 23593973

The incidence and magnitude of fibrinolytic activation in trauma patients: a rebuttal.

C R Ramos, E E Moore, M L Manco-Johnson, C C Silliman, M C Chapman, A Banerjee.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 23593973 PMCID： PMC4074078 DOI： 10.1111/jth.12240

Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824

× No keyword cloud information.

14 in total

1. Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation.

Authors: S Osdoit; J P Rosa
Journal: J Biol Chem Date: 2000-11-17 Impact factor: 5.157

2. An evaluation of the euglobulin method for the determination of fibrinolysis.

Authors: E KOWALSKI; M KOPEC
Journal: J Clin Pathol Date: 1959-05 Impact factor: 3.411

3. Changes in blood coagulation.

Authors: K N Von Kaulla; H Kaye; E von Kaulla; T L Marchioro; T E Starzl
Journal: Arch Surg Date: 1966-01

4. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation.

Authors: Y G Kang; D J Martin; J Marquez; J H Lewis; F A Bontempo; B W Shaw; T E Starzl; P M Winter
Journal: Anesth Analg Date: 1985-09 Impact factor: 5.108

5. Early coagulopathy in trauma patients: an on-scene and hospital admission study.

Authors: Bernard Floccard; Lucia Rugeri; Alexandre Faure; Marc Saint Denis; Eileen Mary Boyle; Olivier Peguet; Albrice Levrat; Christian Guillaume; Guillaume Marcotte; Alexandre Vulliez; Etienne Hautin; Jean Stéphane David; Claude Négrier; Bernard Allaouchiche
Journal: Injury Date: 2010-11-26 Impact factor: 2.586

6. Prevention of in vitro fibrinogenolysis during laboratory monitoring of thrombolytic therapy with streptokinase or APSAC.

Authors: J J Hoffmann; M Vijgen
Journal: Blood Coagul Fibrinolysis Date: 1991-04 Impact factor: 1.276

7. Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activator.

Authors: H D Garabedian; H K Gold; R C Leinbach; T Yasuda; J A Johns; D Thornton; D Collen
Journal: Thromb Res Date: 1988-04-01 Impact factor: 3.944

The incidence and magnitude of fibrinolytic activation in trauma patients: a rebuttal.

1. Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation.

2. An evaluation of the euglobulin method for the determination of fibrinolysis.

3. Changes in blood coagulation.

4. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation.

5. Early coagulopathy in trauma patients: an on-scene and hospital admission study.

6. Prevention of in vitro fibrinogenolysis during laboratory monitoring of thrombolytic therapy with streptokinase or APSAC.

7. Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activator.

8. A new euglobulin clot lysis assay for global fibrinolysis.

9. Epidemiology of trauma deaths: a reassessment.

10. The incidence and magnitude of fibrinolytic activation in trauma patients.

Review 1. Time Course of Hemostatic Disruptions After Traumatic Brain Injury: A Systematic Review of the Literature.

2. Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.

3. Polymorphisms on PAI-1 and ACE genes in association with fibrinolytic bleeding after on-pump cardiac surgery.